SecSonar.com

Anteris Technologies Global Corp. (AVR)

Anteris Technologies Global Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Anteris Technologies Global Corp. (AVR) is a Medical - Devices company based in AU with a market capitalization of $314.1M. Revenue declined 29.2% year-over-year and free cash flow was negative at -$79.8M. This page tracks AVR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 136 employees · IPO Dec 13, 2024

Valuation

Valuation & price

$9.29 · as of May 26, 2026 · -10.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.40$6.65$2.90Jul 25Dec 25Jul 26Jul 7, 25$3.48Jul 9, 25$3.35Jul 11, 25$3.18Jul 15, 25$2.90Jul 17, 25$3.12Jul 21, 25$3.01Jul 23, 25$3.30Jul 25, 25$3.25Jul 29, 25$3.20Jul 31, 25$3.21Aug 4, 25$3.43Aug 6, 25$3.80Aug 11, 25$3.50Aug 13, 25$4.06Aug 15, 25$4.04Aug 19, 25$3.66Aug 21, 25$3.82Aug 25, 25$3.70Aug 27, 25$3.66Aug 29, 25$4.02Sep 3, 25$4.10Sep 5, 25$4.16Sep 9, 25$4.64Sep 11, 25$5.00Sep 16, 25$5.71Sep 18, 25$5.40Sep 22, 25$4.90Sep 24, 25$4.43Sep 26, 25$4.29Sep 30, 25$4.50Oct 2, 25$4.40Oct 6, 25$4.40Oct 8, 25$4.78Oct 10, 25$4.61Oct 14, 25$4.57Oct 16, 25$4.96Oct 21, 25$6.35Oct 23, 25$5.59Oct 27, 25$5.23Oct 29, 25$4.40Oct 31, 25$4.49Nov 4, 25$4.27Nov 6, 25$4.03Nov 10, 25$3.96Nov 12, 25$3.89Nov 14, 25$3.69Nov 18, 25$3.51Nov 20, 25$3.38Nov 25, 25$3.85Nov 28, 25$4.10Dec 2, 25$4.18Dec 4, 25$4.54Dec 8, 25$4.77Dec 10, 25$5.33Dec 12, 25$4.98Dec 16, 25$4.95Dec 18, 25$5.47Dec 22, 25$5.32Dec 24, 25$5.41Dec 29, 25$5.25Jan 2, 26$4.92Jan 6, 26$4.96Jan 8, 26$4.84Jan 12, 26$4.55Jan 14, 26$4.51Jan 16, 26$5.11Jan 21, 26$6.06Jan 23, 26$6.46Jan 27, 26$6.31Jan 29, 26$6.25Feb 2, 26$6.15Feb 4, 26$5.57Feb 9, 26$5.61Feb 11, 26$5.72Feb 13, 26$5.71Feb 18, 26$5.72Feb 20, 26$5.68Feb 24, 26$6.20Feb 26, 26$6.34Mar 2, 26$6.62Mar 4, 26$6.35Mar 6, 26$6.20Mar 10, 26$6.38Mar 12, 26$6.58Mar 17, 26$5.97Mar 19, 26$5.89Mar 23, 26$5.47Mar 25, 26$5.53Mar 27, 26$5.19Mar 31, 26$5.55Apr 2, 26$5.50Apr 7, 26$5.32Apr 9, 26$5.51Apr 13, 26$6.20Apr 15, 26$6.29Apr 17, 26$6.07Apr 22, 26$5.69Apr 24, 26$5.58Apr 28, 26$5.68Apr 30, 26$6.15May 4, 26$6.13May 6, 26$6.39May 8, 26$6.58May 12, 26$6.70May 14, 26$7.25May 18, 26$7.57May 20, 26$8.62May 22, 26$9.62May 28, 26$8.77Jun 1, 26$9.10Jun 3, 26$8.95Jun 5, 26$9.64Jun 9, 26$9.47Jun 11, 26$9.31Jun 15, 26$9.42Jun 17, 26$9.50Jun 22, 26$9.59Jun 24, 26$10.40Jun 26, 26$9.69Jul 2, 26$10.24
$2.9052-week range$10.40
Loading valuation history…

Fundamentals

Key fundamentals

$314.1M

Market cap

-29.2%

Revenue growth (YoY)

-16.6%

Gross margin

-$79.8M

Free cash flow (USD)

-$10.3M

Net debt

Net cash position

16.4%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$5.5MFY 2021$5.8MFY 2022$3.2MFY 2023$2.7MFY 2024$2.7MFY 2025$1.9M
$5.5M$1.9M

Free cash flow by year

2020 → 2025

FY 2020$-11.3MFY 2021$-15.0MFY 2022$-31.1MFY 2023$-37.0MFY 2024$-63.5MFY 2025$-79.8M
-$11.3M-$79.8M

Gross margin by year

2021 → 2025

FY 202132.7%FY 20229.3%FY 202332.1%FY 202446.8%FY 2025-16.6%
32.7%-16.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJul 1, 2026Filing
  • Insider buyInsider Buy $102KKnight Susan Elizabeth · Director · $102.2KJun 4, 2026Filing
  • 8-K eventCommon Stock Sales AgreementMay 22, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • 8-K eventDirector AppointmentsMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventTermination of AgreementApr 29, 2026Filing
  • 8-K eventLease AgreementApr 23, 2026Filing

Questions

Frequently asked questions

What is Anteris Technologies Global Corp.'s market cap?

Anteris Technologies Global Corp. (AVR) has a market capitalization of $314.1M.

What is AVR's P/E ratio?

A meaningful P/E ratio is not available for AVR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying AVR stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Anteris Technologies Global Corp. in the last 90 days.

Same arena

Related companies in Medical - Devices

CATX

Perspective Therapeutics, Inc.

$310.2M

ELMD

Electromed, Inc.

$318.5M

MASS

908 Devices Inc.

$322.7M

SENS

Senseonics Holdings, Inc.

$280.3M

SGHT

Sight Sciences, Inc.

$270.1M

DCTH

Delcath Systems, Inc.

$368.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.